Clinical Trial Update: Low Dose of Hydrocortisone and Fludrocortisone in Adult Cardiogenic Shock. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating low-dose hydrocortisone and fludrocortisone in adult cardiogenic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Drugs mentioned

• Fludrocortisone (Fludrocortisone)
• HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: CMC Ambroise Paré | Conditions: Cardiogenic Shock | Phase 3 | Status: COMPLETED